Vertex to Present at the Bank of America Securities 2021 Virtual Health Care Conference on May 13
May 10 2021 - 9:01AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will present at the Bank of America
Securities 2021 Virtual Health Care Conference on Thursday, May 13,
2021 at 10:15 a.m. ET.
The audio portion of management's remarks will be available live
through Vertex's website, www.vrtx.com in the "Investors" section
under the "News and Events" page. A replay of the conference
webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has multiple approved medicines
that treat the underlying cause of cystic fibrosis (CF) — a rare,
life-threatening genetic disease — and has several ongoing clinical
and research programs in CF. Beyond CF, Vertex has a robust
pipeline of investigational small molecule medicines in other
serious diseases where it has deep insight into causal human
biology, including pain, alpha-1 antitrypsin deficiency and
APOL1-mediated kidney diseases. In addition, Vertex has a rapidly
expanding pipeline of genetic and cell therapies for diseases such
as sickle cell disease, beta thalassemia, Duchenne muscular
dystrophy and type 1 diabetes mellitus.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London. Additionally, the company
has research and development sites and commercial offices in North
America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 11 consecutive years on Science magazine's Top
Employers list and a best place to work for LGBTQ equality by the
Human Rights Campaign. For company updates and to learn more about
Vertex's history of innovation, visit www.vrtx.com or follow us on
Facebook, Twitter, LinkedIn, YouTube and Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210510005101/en/
Vertex Pharmaceuticals Incorporated Investors: Michael
Partridge, 617-341-6108 Brenda Eustace, 617-341-6187 Manisha Pai,
617-429-6891
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Sep 2023 to Sep 2024